Trial intelligence / Profile preview

Oxycodone for anesthesia in gynecological day hysteroscopic surgery

ChiCTR2300078799Phase 4Recruiting

Sponsor
Weifang Maternal and Child Health Care Hospital
Start
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of oxycodone in endometrial polyp and Fibromyoma (LM) (2 arms), sponsored by Weifang Maternal and Child Health Care Hospital. Primary endpoint: Visual analog scale (VAS) for pain. Started Dec 2023; status: recruiting.

02

Drugs

oxycodone
03

Conditions

endometrial polypFibromyoma (LM)

Beyond the preview

Go deeper on ChiCTR2300078799.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300078799.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call